Rising adoption of third-party quality controls, increasing number of accredited clinical laboratories, and the rising demand for external quality assessment support are the key factor driving market growth.
The Molecular Quality Controls Market is expected to
grow from USD 132 million in 2018 to USD 237 million by 2024, at a CAGR of
10.2% during the forecast period.
Ask
for PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82625523
Market
Segmentation:-
Based on product
type, the molecular controls market is divided into two major
segments—instrument-specific controls and independent controls. The independent
controls segment accounted for a larger share of the molecular controls market
in 2018. The large share of this segment is attributed to the increasing use of
third-party independent quality controls due to their benefits such as longer
shelf-life and flexible use across different reagent lots, which help reduce
the cost of operations.
By analyte type, the
molecular controls market is segmented into single-analyte controls and
multi-analyte controls. Single-analyte controls dominated the molecular
controls market in 2018 primarily due to the significant use of singleplex
assays in hospitals and the advantages associated with the use of
single-analyte controls, such as simple analysis & interpretation and low
risk of cross-reactivity.
Recent
Developments:-
- In
2018, Seracare partnered with AccuRef Diagnostics, a division of Applied
StemCell, Inc (US), to market and sell Accuref’s broad portfolio of
CRISPR-engineered cell line reference materials.
- In
2018, Thermo Fisher Scientific partnered with West China Hospital of
Sichuan University (China) to establish training centers for standardized
pathology quality control, standardized pathologic diagnosticians, and
advanced laboratories.
- In
2017, Bio-Rad launched Amplichek STI—a Multi-analyte Quality Control
- In
2018, Microbiologics launched 8 quality control products such as, Human
Papillomavirus (HPV) Control Panel, Vaginal Control Panel, Vaginal
Verification Panel, Blood Culture (BCID) Control Panel, Enteric Viral
Control Panel and others.
Regional
Analysis:-
North America held
the largest share of the market in 2018, Asia Pacific is estimated to grow at
the highest CAGR during the forecast period.
Request
for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=82625523
Top
Key Players:-
The prominent players
in the molecular quality controls market are SeraCare Life Sciences Inc. (US),
ZeptoMetrix Corporation (US), Bio-Rad Laboratories Inc. (US), Microbiologics
Inc. (US), and Thermo Fisher Scientific (US).
No comments:
Post a Comment